Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease

British Journal of Urology

Volumn 81, Issue 5, 1998, Pages 666-672

  Stapleton, A M F ^a   Timme, T L ^b   Ryall, R L ^c,d  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d Department of Surgery ^*

Author keywords

Calcium oxalate; Kidney stones; Macromolecules; Prothrombin; Urinary inhibitors

Indexed keywords

CALCIUM OXALATE; MESSENGER RNA; PROTHROMBIN; RNA;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY; LIVER; NEPHROLITHIASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPLEEN; STONE FORMATION;

BIOLOGICAL MARKERS; BLOTTING, SOUTHERN; CALCIUM OXALATE; GENE EXPRESSION; HUMANS; KIDNEY CALCULI; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; PROTHROMBIN; RNA, MESSENGER;

EID: 0031819214     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00620.x     Document Type: Article

References (31)

1. Fleisch H. Inhibitors and promoters of stone formation. Kidney M 1978; 13: 361-71
2. Coe FL, Nakagawa Y, Parks JH. Inhibitors within the nephron. Am J Kidney Dis 1991; 17; 407-13
3. Leal JJ, Finlayson B. Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces. Invest Urol 1977; 14: 278-83
4. Blomen LJMJ, Bijvoet OLM. Physicochemical consideration in relation to urinary stone formation. World J Urol 1983; 1: 11-25
5. Addadi L, Berkovitch-Yellin Z, Domb N, Gati E, Lahav M, Leiserowitz L. Resolution of conglomerates by stereoselective habit modifications. Nature 1982; 296: 21-6
6. Nancollas GH, Gardner GL. Kinetics of crystal growth of calcium oxalate monohydrate. J Crystal Growth 1974; 21: 267-76
7. Ryall RL, Stapleton AMF. Urinary macromolecules in calcium oxalate stone and crystal matrix: good, bad, or indifferent. In: Khan SR, ed. Calcium oxalate in biological systems. Boca Raton: CRC Press, 1995: 265-90
8. Ryall R, Grover P. Stapleton A et al. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted urine in vitro. Clin Sci 1995; 89: 533-41
9. Stapleton AMF, Ryall RL. Crystal matrix protein - getting blood out of a stone. Miner Electrol Metab 1994; 20: 399-409
10. Doyle IR, Ryall RL, Marshall VR. Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clin Chem 1991; 37: 1589-94
11. Stapleton AMF, Dawson CJ, Grover PK et al. Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix. Kidney Int 1996; 49: 880-8
12. Stapleton AMF, Simpson RJ, Ryall RL. Crystal matrix protein is related to human prothrombin. Biochem Biophys Res Commun 1993; 195: 1199-203
13. Stapleton A, Ryall R. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin. Br J Urol 1995; 75: 712-9
14. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochem 1991; 30: 10363-70
15. Burnier JP, Borowski M, Furie BC, Furie B. Gamma-carboxyglutamic acid. Mol Cell Biochem 1981; 39: 191-9
16. Romberg RW, Werness PG, Riggs BL, Mann KG. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 1986; 25: 1176-80
17. Kisiel W, Hanahan DJ. The action of factor Xa, thrombin and trypsin on human factor II. Biochim Biophys Acta 1973; 329: 221-32
18. Bezeaud A, Guillin M-C. Quantitation of prothrombin activation products in human urine. Br J Haematol 1984; 58: 597-606
19. Stapleton AMF. Crystal Matrix Protein and Urolithiasis: Getting Blood Out of a Stone [PhD thesis]. Adelaide: Flinders University of South Australia. 1995
20. Stapleton AMF, Seymour AE, Brennan JS, Doyle IR, Marshall VR, Ryall RL. The immunohistochemical distribution and quantification of crystal matrix protein. Kidney Int 1993; 44: 817-24
21. Thompson TC, Park SH, Timme TL et al Loss of p53 function leads to metastasis in ras + myc-initiated mouse prostate cancer. Oncogene 1995; 10: 869-79
22. Doyle IR. The Role of Urinary Proteins in Calcium Oxalate Urolithiasis [PhD thesis]. Adelaide: Flinders University of South Australia, 1992
23. Hauschka P, Friedman P, Traverso H, Gallop P. Vitamin K-dependent γ-carboxyglutamic acid formation by kidney microsomes in vitro. Biochem Biophys Res Commun 1976; 71: 1207-13
24. Jamison CS, Degen SJF. Prenatal and postnatal expression of mRNA coding for rat prothrombin. Biochim Biophys Acta 1991; 1088: 208-16
25. Sekiya F, Usui H, Inoue K, Fukudome K, Morita T. Activation of prothrombin by a novel membrane-associated protease. An alternative pathway for thrombin generation independent of the coagulation cascade. J Biol Chem 1994; 269: 32441-5
26. Tapparelli C, Metternich R, Cook NS. Structure and function of thrombin receptors. Trends Pharmacol Sci 1993; 14: 426-8
27. Friezner Degen SJ. The prothrombin gene and its liver-specific expression. Semin Thromb Haem 1992; 18: 230-42
28. Suzuki K, Suga K, Miyazawa K, Tsugawa R. Where is the origin of crystal matrix protein? -expression of prothrom-bin mRNA in human and rat kidney. Br J Urol (Supp 2) 1997; 80: 322
29. Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 1991; 6: 575-81
30. Jalink K, Moolenaar WH. Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messages. J Cell Biol 1992; 118: 411-9
31. Gurwitz D, Cunningham DD. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 1988; 85: 3440-4